Seattle Genetics Achieves Milestones as Genentech Advances Two Antibody …
Seattle Genetics Achieves Milestones as Genentech Advances Two Antibody …
Filed under: Seattle Drug Treatment Help
Seattle Genetics is a biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer. The U.S. Food and Drug Administration granted accelerated approval of ADCETRIS in …
Read more on DailyFinance
States Legalizing Marijuana Will Violate Federal Law, Trigger Constitutional …
Filed under: Seattle Drug Treatment Help
Drug treatment admissions are up and the number of teens using this gateway drug is up dramatically." Bensinger was joined by a host of speakers … It would help enormously and I think it would defeat these measures." Both Colorado and Washington's …
Read more on Huffington Post
Cell Therapeutics wins orphan-drug status; stock climbs
Filed under: Seattle Drug Treatment Help
Orphan drug status is awarded to drugs that are intended to treat rare diseases. Shares of Cell Therapeutics closed up 29 cents, or 13 percent, at $ 2.52. Over the past year, shares have traded between $ 1.77 and $ 8.25. The Seattle company said …
Read more on The Seattle Times
More Seattle Drug Treatment Help Resources
… Retrieve ContentGenentech, Inc. and Biogen IDEC developed Rituxan, which generates billions of USDs in annual sales. and Society; Conservation Biology and Ecological Sustainability; Ecology and Evolution; Genetics The Hutchinson Center, based in Seattle, is a leader in using molecular diagnostics for the early … Visit Document
… Return DocumentThese advances have been published in 20 major studies and have generated more than $ day one, Alder has worked to make a significant contribution to the field of antibody therapeutics using two 19-July-2010: Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program … Doc Viewer